^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    JSI-1187

    i
    Other names: JSI-1187, JSI-1187-01, JSI1187, JSI 1187, JSI118701, JSI 1187 01
    Company:
    JS InnoPharm
    Drug class:
    ERK2 inhibitor, ERK1 inhibitor
    Related drugs:
    Apply
    JSI-1187-01 Monotherapy and in Combination With Dabrafenib for Advanced Solid Tumors With MAPK Pathway Mutations (NCT04418167)
    Phase 1
    JS InnoPharm, LLC
    Suspended
    Last update posted :
    02/02/2024
    Initiation :
    06/18/2020
    Primary completion :
    06/30/2024
    Completion :
    12/17/2024
    MAP2K1 • NF1 • RASA1
    |
    BRAF V600E • BRAF V600K
    |
    Tafinlar (dabrafenib) • JSI-1187